Wei Ouyang
McGill University
22 Papers
260 Citations
Wei Ouyang is an academic researcher from McGill University. The author has contributed to research in topics: Genipin & Chemistry. The author has an hindex of 11, co-authored 18 publications.
Chat about Author
Papers
Microencapsulated Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol.
TL;DR: It is shown that microencapsulated Lactobacillus plantarum 80 (pCBH1) cells can efficiently break down and remove bile acids, and establishes a basis for their use in lowering blood serum cholesterol.
Genipin cross-linked alginate-chitosan microcapsules: membrane characterization and optimization of cross-linking reaction.
TL;DR: The details of the microcapsule membrane characterization using a noninvasive and in situ method without any physical or chemical modifications on the samples showed that the cross-linking reaction generated the fluorescent chitosan-genipin conjugates.
102
Reaction of chitosan with genipin and its fluorogenic attributes for potential microcapsule membrane characterization.
TL;DR: Findings demonstrate a convenient and effective way of characterizing chitosan-based microcapsules using genipin as a fluorogenic marker, a technique that will be useful in microcapsule research and other biomedical applications.
94
Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules.
Tasima Haque,Hongmei Chen,Wei Ouyang,Christopher Martoni,Bisi Lawuyi,and Aleksandra Malgorzata Urbanska,Satya Prakash +6 more
TL;DR: The study revealed the potential of using PEG-incorporated alginate, chitosan, and PLL microcapsules for encapsulating live cells producing proteins and hormones for therapy and revealed the highest cell viability and mechanical strength when exposed to external rotational force.
80
Dexamethasone-loaded ROS-responsive poly(thioketal) nanoparticles suppress inflammation and oxidative stress of acute lung injury
TL;DR: In this article , a therapeutic nanoplatform with reactive oxygen species (ROS)-responsiveness was developed for the regulation of inflammation, which is associated with excessive inflammatory response, leading to acute respiratory distress syndrome (ARDS) without timely treatment.
67